Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Beckman Coulter Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7239
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offers its instruments, comprehensive diagnostic tests and business management services to hospitals, laboratories and other critical care settings worldwide. It provides scientific solutions for laboratory customers such as universities, biotechnology and pharmaceutical companies, government, hospitals, and commercial laboratories. It operates across the US, Canada, Europe and Asia with clinical and research systems operating in laboratories around the world. Beckman is headquartered in California, the US.

Beckman Coulter Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Beckman Coulter Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 10
Partnerships 11
Grifols and Beckman Coulter Enter into Distribution Agreement 11
DiaSorin Enters into Agreement with Beckman Coulter 12
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 13
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 14
CellaVision Expands Distribution Agreement With Beckman Coulter 15
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 16
Asset Transactions 17
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 17
Acquisition 18
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 18
Beckman Coulter Inc – Key Competitors 19
Beckman Coulter Inc – Key Employees 20
Beckman Coulter Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Jun 21, 2018: UCI, Beckman Coulter Diagnostics announce strategic collaboration 25
Product News 26
Jun 19, 2018: Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males 26
Jan 04, 2018: Beckman Coulter Diagnostics Adds 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) Assays to Comprehensive Chemistry Test Menu 27
Jul 31, 2017: Beckman Coulter Highlights the First US IVD Test Delivering Flow Cytometric Leukemia & Lymphoma Analysis in the Routine Clinical Lab 28
Jun 05, 2017: Beckman Coulter Expands Role of AQUIOS CL Flow Cytometer in Routine Labs 30
Apr 20, 2017: Beckman Coulter Diagnostics Receives CE Mark and Expands Chemistry Menu to include Procalcitonin (PCT)Beckman Coulter Sample 31
Other Significant Developments 32
Jul 19, 2018: Beckman Coulter announces launch of DxONE PROService in Europe 32
Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 33
Jul 27, 2017: Beckman Coulter Diagnostics Introduces DxONE Clinical Information Management Tools 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Beckman Coulter Inc, Medical Equipment, Key Facts 2
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Deals By Market, 2012 to YTD 2018 8
Beckman Coulter Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 10
Grifols and Beckman Coulter Enter into Distribution Agreement 11
DiaSorin Enters into Agreement with Beckman Coulter 12
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 13
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 14
CellaVision Expands Distribution Agreement With Beckman Coulter 15
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 16
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 17
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 18
Beckman Coulter Inc, Key Competitors 19
Beckman Coulter Inc, Key Employees 20
Beckman Coulter Inc, Other Locations 22
Beckman Coulter Inc, Subsidiaries 22
Beckman Coulter Inc, Joint Venture 24

List of Figures
Beckman Coulter Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Beckman Coulter Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Beckman Coulter Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Beckman Coulter Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Beckman Coulter Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Axalta Coating Systems Ltd.:戦略・SWOT・企業財務分析
    Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Interglobe Aviation Limited:戦略・SWOT・企業財務分析
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nordea Bank AB:企業のM&A・事業提携・投資動向
    Nordea Bank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordea Bank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • Millicom International Cellular SA (MIC SDB):企業の財務・戦略的SWOT分析
    Millicom International Cellular SA (MIC SDB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Sumitomo Mitsui Trust Holdings Inc:企業の戦略・SWOT・財務分析
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Waste Management Inc (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management Inc (WM) is a provider of waste management environmental services. The company has presence in the waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. Through its personal counseli …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Meiji Seika Pharma Co Ltd:企業のM&A・事業提携・投資動向
    Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Meiji Seika Pharma Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Endava Limited:企業の戦略・SWOT・財務情報
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務分析
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bio Blast Pharma Ltd (ORPN):企業の財務・戦略的SWOT分析
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆